REGN
Regeneron Pharmaceuticals, Inc.
Stock
$735.20+0.39 (+0.05%)Close Oct 2, 2026
- Cash and short-term investments, 2025
- $8.6B
- YoY, 2025
- −4.5%
- 5-year CAGR
- +19.1%
- 10-year CAGR
- +23.5%
Cash and short-term investments
Cash and short-term investments by fiscal year
| Period | Cash | YoY |
|---|---|---|
| 2025 | $8.6B | −4.5% |
| 2024 | $9.0B | −16.9% |
| 2023 | $10.8B | +40.1% |
| 2022 | $7.7B | +36.0% |
| 2021 | $5.7B | +58.8% |
| 2020 | $3.6B | +11.6% |
| 2019 | $3.2B | +14.4% |
| 2018 | $2.8B | +99.4% |
| 2017 | $1.4B | +35.7% |
| 2016 | $1.0B | −0.6% |
| 2015 | $1.0B | +16.1% |
| 2014 | $900M | +29.8% |
| 2013 | $694M | +125.3% |
| 2012 | $308M | −41.5% |
| 2011 | $527M | +111.3% |
| 2010 | $249M | −26.9% |
| 2009 | $341M | +37.7% |
| 2008 | $248M | — |